Literature DB >> 31872890

The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.

Davide Rossi1,2, David M Kurtz3, Mark Roschewski4, Franco Cavalli1, Emanuele Zucca1,2, Wyndham H Wilson4.   

Abstract

This report summarizes a closed workshop cosponsored by the American Association for Cancer Research, the European School of Oncology, and the 15th-International Conference on Malignant Lymphoma to discuss critical open questions on liquid biopsy in lymphoid malignancies, develops a roadmap for their analytical and clinical validation, and prioritizes research areas.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cell-free DNA; circulating tumor DNA; lymphoma

Mesh：

Substances：

Year:  2019        PMID： 31872890     DOI： 10.1002/hon.2704

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


  8 in total

1.  Expanding the Precision Medicine Toolkit With Circulating Tumor DNA.

Authors:  Mark Roschewski; Wyndham H Wilson
Journal:  JCO Oncol Pract       Date:  2020-09

2.  Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.

Authors:  Kazuyuki Shimada; Kenichi Yoshida; Yasuhiro Suzuki; Chisako Iriyama; Yoshikage Inoue; Masashi Sanada; Keisuke Kataoka; Masaaki Yuge; Yusuke Takagi; Shigeru Kusumoto; Yasufumi Masaki; Takahiko Ito; Yuichiro Inagaki; Akinao Okamoto; Yachiyo Kuwatsuka; Masahiro Nakatochi; Satoko Shimada; Hiroaki Miyoshi; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Yusuke Shiozawa; Yasuhito Nannya; Asako Okabe; Kei Kohno; Yoshiko Atsuta; Koichi Ohshima; Shigeo Nakamura; Seishi Ogawa; Akihiro Tomita; Hitoshi Kiyoi
Journal:  Blood       Date:  2021-03-18       Impact factor: 22.113

Review 3.  Circulating Tumor DNA in Lymphoma: Principles and Future Directions.

Authors:  Mark Roschewski; Davide Rossi; David M Kurtz; Ash A Alizadeh; Wyndham H Wilson
Journal:  Blood Cancer Discov       Date:  2021-09-30

Review 4.  Liquid biopsy in lymphoma: Is it primed for clinical translation?

Authors:  Edward Poynton; Jessica Okosun
Journal:  EJHaem       Date:  2021-05-12

5.  Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma.

Authors:  Rahul Lakhotia; Christopher Melani; Kieron Dunleavy; Stefania Pittaluga; Nakhle Saba; Liza Lindenberg; Esther Mena; Ethan Bergvall; Andrea Nicole Lucas; Allison Jacob; Erik Yusko; Seth M Steinberg; Elaine S Jaffe; Adrian Wiestner; Wyndham H Wilson; Mark Roschewski
Journal:  Blood Adv       Date:  2022-04-26

Review 6.  Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.

Authors:  Eliza M Lauer; Jurik Mutter; Florian Scherer
Journal:  Leukemia       Date:  2022-06-14       Impact factor: 12.883

7.  ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma.

Authors:  José Díaz-Chávez; Olga Gutiérrez-Hernández; Lucia Taja-Chayeb; Sindy Gutiérrez-Chavarría; Alejandro Avilés-Salas; Myrna Candelaria
Journal:  Cancers (Basel)       Date:  2022-09-24       Impact factor: 6.575

8.  Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab.

Authors:  Alessio Bruscaggin; Lodovico Terzi di Bergamo; Valeria Spina; Brendan Hodkinson; Gabriela Forestieri; Ferdinando Bonfiglio; Adalgisa Condoluci; Wei Wu; Maria C Pirosa; Martin R Faderl; Ricardo Koch; Michael Schaffer; John D Alvarez; Nele Fourneau; Bernhard Gerber; Georg Stussi; Emanuele Zucca; Sriram Balasubramanian; Davide Rossi
Journal:  Blood Adv       Date:  2021-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.